The purpose of this study was to determine the effects of local infusion of adenosine (ADO) and non metabolized ADO analogues on local cerebral blood flow (CBF) and interstitial fluid (ISF) ADO levels. The brain dialysis technique was used to (a) deliver drugs locally to brain tissue, (b) estimate cerebral ISF ADO levels, and (c) measure local CBF (hydrogen clearance). Dialysis probes were implanted bilaterally in the caudate nuclei of ketamine-anesthetized rats. The probe on one side was perfused with artificial CSF while the contralateral probe was perfused with artificial CSF containing ADO (n = 5), or the ADO agonists 2-chloroadenosine (2-CADO; n = 4) or 5'-N-ethylcarboxamide adenosine (NECA; n = 4).
The vasodilator adenosine was first proposed as a metabolic mediator of cerebral blood flow (CBP) in 1974 (Berne et aI., 1974) . Since that time, evidence has accumulated both for (Rubio et aI., 1975; Schrader et aI., 1980; Winn et aI., 1979 Winn et aI., , 1980a Winn et aI., , 1980b Emerson and Raymond, 198 1; Hoff man et aI., 1984; Phillis et aI., 1984 Phillis et aI., , 1985 Phillis et aI., , 1987 Morii et aI., 1987) and against (Dora et aI., 1984; Dora, 1986; McPhee and Maxwell, 1987) a role of adenosine in the regulation of CBP. One of the lim iting factors in the study of adenosine and CBP reg-ulation has been the inability to determine changes in the cerebral interstitial fluid (ISP) adenosine con centration in response to various interventions. To address this limitation, we have applied the brain dialysis technique, whereby cerebral ISP can be sampled, to the study of CBP regulation by adeno sine. These studies, along with an earlier study by Zetterstrom et aI. (1982) , have provided evidence in adult and newborn animals that adenosine partici pates in the regulation of CBP during hypoxia (Van Wylen et aI., 1986; Park et aI., 1987a) and increased metabolic activity (Van Wylen et aI., 1986 , 1988b Park et aI., 1987 b ), but perhaps not during cerebral autoregulation (Park et aI., 1988; Van Wylen et aI., 1988a) .
We recently modified the brain dialysis technique to incorporate a measurement of local CBP via the hydrogen clearance technique (Van Wylen et aI., 1988a) . This modification allows both local CBF and ISF adenosine changes to be monitored in re-sponse to drugs applied locally through the dialysis probe, a distinct advantage in that systemic cardio vascular changes are avoided. The purpose of the present study was to use the modified brain dialysis technique to determine the changes in local CBF and ISF adenosine levels produced by locally in fused adenosine and nonmetabolizable adenosine analogues.
METHODS

Brain dialysis technique
The modified brain dialysis technique used in these ex periments has been described in detail previously (Van Wylen et al., 1988a) . In brief, the dialysis probes consist of a single hollow dialysis fiber (Clirans TH 10; inner diameter of 300 fLm; molecular weight cutoff of 5,000 dal tons), into which are placed two hollow silica tubes (inner diameter of 75 fLm, outer diameter of 150 fLm; Friedrich & Dimmock, Inc., Millville, NJ, U.S.A.) and a platinum wire (bare diameter of 10 fLm; Medwire, Inc., Mt. Veron, NY, U.S.A.). The silica tubes are positioned and sealed within the dialysis fiber such that there is a 5 mm distance between the ends of the two tubes. Once the dialysis probes are implanted in the brain, the inflow silica tube is connected to a syringe filled with artificial cerebrospinal fluid (CSF) and perfused at 0.1 fLUmin (Carnegie Medicin AB model CMA100 microinjection pump, Lafayette, IN, U.S.A.). The effluent is collected from the outflow silica tube for 10 min sample periods in plastic tubes. The arti ficial CSF consists of (in mM) NaCl, 132.8; NaHC03, 24.6; urea, 6.7; glucose, 3.7; KCl, 3.0; CaClz, 2.0; and MgClz, 1.4 .
Measurement of local CBF
Local CBF is measured from the area surrounding the dialysis probe by the hydrogen clearance technique (Auk land et ai., 1964; Pasztor et ai., 1973; Young, 1980) . An electronic circuit similar to that described by Pasztor et ai. (1973) is used to amplify the current from the platinum wire within the dialysis probe. The platinum wire within the dialysis probe is polarized to 475 m V against a self tapping stainless-steel screw reference electrode inserted into the parietal skull. Hydrogen (7-10%) is added to the inspired air for approximately 2 min, after which the in spired hydrogen is turned off and the washout of hydro gen from the tissue is monitored. Local CBF is calculated from the time required for the hydrogen levels to fall from 90% maximum to 40% maximum using the formula CBF (mlimin/1oo g)
Animal preparation
-In(40/90) .
x 100 hme Adult Wistar rats weighing 300-500 g were anesthetized with ketamine/xylazine (80 mg/kg ketamine, 8 mg/kg xy lazine, i.p.), tracheostomized, and artificially ventilated (Harvard 680 rodent respirator, Natick, MA, U.S.A.) with a mixture of oxygen and nitrogen. Tidal volume, respiratory rate, and percent oxygen in the inspired gas were adjusted to maintain normal blood gas values (Corn ing 158 pHlblood gas analyzer, Medfield, MA, U.S.A.). Core body temperature was monitored with a rectal tem perature probe and maintained between 37 and 38°C with a heating pad. The left femoral artery was cannulated for the measurement of arterial blood pressure (Statham model P23Db pressure transducer; Gould 2400 recorder, Greenbelt, MD, U.S.A.) and the withdrawal of arterial blood samples. The left femoral vein was cannulated for the maintenance of a constant infusion of ketamine (0.6 mg/kg/min).
Brain dialysate samples were collected bilaterally from the caudate nucleus. In preparation for implantation of the dialysis probes in the brain, animals were placed in a stereotaxic apparatus and the frontal and parietal bones of the skull were exposed. Burr holes were made bilater ally 0.5 mm anterior and 2.5 mm lateral to the bregma and the dialysis probes were lowered 8 mm below the dura mater such that the 5 mm length of dialysis fiber between the ends of the two silica tubes rested in the caudate nucleus (Pellegrino et ai., 1979) . Following implantation, the dialysis probes were cemented into place with dental acrylic and a minimum 90 min recovery period elapsed prior to the initiation of experimental protocols. The 90 min recovery period was chosen because previous studies indicated that purine levels are elevated immediately fol lowing implantation of the dialysis probe, after which they decline and level off by approximately 90 min (Van Wylen et ai., 1986) .
Protocols
To investigate the effect of local infusion of adenosine and adenosine analogues, four groups of animals were studied. The protocols for these groups are summarized in Table 1 . In groups 1, 2, and 3, the response to locally infused adenosine (group 1) or the adenosine receptor agonists 2-chloroadenosine (2-CADO; group 2) and 5'-N-ethyicarboxamide adenosine (NECA; group 3) was determined. In these protocols, the dialysis probe on the control side was perfused throughout the experiment with artificial CSF while the dialysis probe on the experimen tal side was first perfused with artificial CSF, then with artificial CSF containing increasing concentrations of the drug, and finally with artificial CSF without the drug. Approximately 10 min were required to change perfusate solutions between samples. In group 4, we attempted to block the NECA response with the adenosine receptor antagonist 8-(p-sulfophenyl)-theophylline (SPT). In these expenments, the control Side was first perfused with ar tificial CSF, and then with artificial CSF containing NECA throughout the remainder of the experiment. The first perfusions on the experimental side were the same as on the control side, after which the probe was perfused with artificial CSF containing NECA and progressively greater concentrations of SPT.
Analytical procedures
The perfusate samples were analyzed for adenosine, inosine, and hypoxanthine using reverse phase high performance liquid chromatography (LKB 2152 control ler, LKB 2150 pumps, Waters 712 WISP autoinjector, Kratos Spectroflow 773 detector, and Kipp & Zonen BD41 recorder). Separation of the compounds of interest was achieved using an Altex Ultrasphere-ODS column and a 1% (pH 4.5) to 25% (pH 5.3) methanol in 100 mM KHzP04 gradient. Peaks were identified and quantified by comparing retention times and peak heights to known standards.
Statistical analysis
A paired t test with a Bonferonni correction for multi ple comparisons was used to make statistical com pari- sons of the mean values of different conditions within the same animals. A p value less than 0. 05 was accepted as indicating a statistically significant difference.
RESULTS
The local infusion of the various compounds did not affect systemic cardiovascular variables or con tralateral local CBP and dialysate adenosine, ino sine, and hypoxanthine concentrations. The control values of the monitored variables, which were not different among the four groups, were pooled and are shown in Table 2 . ble 3 shows the dialysate adenosine, inosine, and hypoxanthine concentrations during the perfusion with adenosine. When the probe was perfused with 10, 100, or ] ,000 J.LM adenosine, 5. 3 ± 0. 8, 36. 3 ± 10.6, and 643.6 ± 136.4 J.LM adenosine, respec tively, were recovered in the effluent. Significant increases in dialysate inosine and hypoxanthine were seen during perfusion with 10-4 and 10-3 M adenosine. Figures 2 and 3 show the CBF response to locally infused 2-CADO and NECA, respectively, plotted in percent of CBF values on the control side. CBF increases were observed at lower concentrations with both 2-CADO and NECA than with adenosine. The first significant increase in CBF with 2-CADO was observed at 10-5 M, and at 10-4 M 2-CADO there was approximately a threefold increase in CBF (Fig. 2) . With NECA, CBF increases were observed at 10 -6 M, reaching 287% of the control side at 10-5 M (Fig. 3) . However, unlike the aden osine response, the 2-CADO response was only slowly reversible and the NECA response was not reversible up to 1 h after the cessation of perfusion with the agonist.
The results from group 4 are shown in Figs. 4 and 5. On the side that received only NECA, an approx imate twofold increase in local CBF was observed and was maintained throughout the experiment (Fig. 4) . On the side of locally infused SPT, NECA produced a similar hyperemia that was not affected by 10-5 M SPT, but was attenuated at 10-4 M SPT and not statistically different from control at 10 -3 M SPT. As seen in Fig. 5 , 10-6 M NECA alone produced approximately a 40% decrease in dialy sate adenosine concentration and was maintained throughout the period of infusion. On the side of the locally infused SPT, NECA produced a similar de crease in dialysate adenosine that was progressively attenuated by increasing amounts of SPT, the val ues at 10-4 and 10-3 M SPT being greater than with NECA alone and not statistically different from control. 3.9 ± 0.7 8.0 ± 0.9* 21.6 ± 2.3* Mean ± SEM dialysate adenosine, inosine, and hypoxanthine concentrations in group I, in which adenosine was infused lo cally into the brain by inclusion in the artificial CSF at 10 -5, 10-4, or 10-3 M. *p < 0.05 as compared to initial CSF condition. 
DISCUSSION
This study investigated a novel approach to the study of local CBF regulation. The brain dialysis technique, modified to incorporate a measurement of local CBF from the tissue surrounding the dialy sis probe, was used to determine changes in CBF and ISF adenosine levels in response to the local infusion of adenosine or adenosine agonists/ antagonists. The primary advantage afforded by this approach is that a micr,oenvironment in the brain is created into which drugs can be delivered and from which changes in CBF and ISF composi tion can be determined. In this manner, systemic cardiovascular and global cerebral changes are avoided.
Using this approach, the major findings of this study were that (a) local adenosine resulted in a measured increase in local CBF only when adeno- sine was included in the perfusate at to -3 M (b) 2-CADO and NECA infuSIOn resulted" in. dose dependent increases in local CBF, and (c) the NECA-induced increase in CBF and decrease in dialysate adenosine concentration could be blocked by the simultaneous infusion of the adenosine re ceptor antagonist SPT. These results, which are consistent with the vascular responses to adenosine and adenosine analogues applied topically to the pial vasculature (Wahl and Kuschinsky, 1976; Greg ory et aI., 1980; Berne et aI., 198 1; Morii et aI., 1986) or to isolated cerebral vessels (McBean et aI., 1988) , suggest that the infusion of drugs locally via the brain dialysis technique may prove useful in the study of local CBF regulation. Since cerebral ISF adenosine concentration in the rat has been estimated to be in the nM to low fJ-M range (Zetterstrom et aI., 1982; Van Wylen et aI., 1986; Phillis et aI., 1987) , we were surprised to observe the high concentration of adenosine in the CSF (10-3 M) required to achieve a relatively small (30%) increase in measured CBF. As indicated by the increases in dialysate inosine and hypoxanthine during adenosine infusion, cellular uptake of ade nosine and metabolism to inosine and hypoxanthine occurred in the tissue surrounding the probe. Thus, we believe that due to the rapid uptake and degra dation of adenosine, there is a discrepancy between the volume of tissue into which adenosine is diffus ing and the volume of tissue from which the hydro gen clearance method is measuring blood flow. In other words, it is likely that the adenosine concen tration throughout the region from which the hydro gen clearance technique is measuring blood flow is kept low by cellular uptake and metabolism, thus requiring an apparently high concentration of ade nosine in the artificial CSF to give a measured in crease in CBF. This concept is supported by a study by Berne et aI. (198 1) , in which a cranial window was used to observe the pial vessels in dogs and to superfuse adenosine or 2-CADO. Superficial cortical blood flow was measured by the 8 5 Kr washout technique. These investigators were unable to detect an in crease in CBF until 10-3 M adenosine was super fused, despite observed pial vessel dilation at 10-7 M adenosine. Subsequent studies with radiolabeled adenosine indicated that 60% of the superfused ad enosine was limited to the outer 100 fJ-m of cortex. In contrast to adenosine, superfusion with 2-CADO not only dilated the pial vessels at concentrations as low as 10 -7 M, but also resulted in increased CBF . The interpretation of these results was that 2-CADO, which is metabolized less rapidly than ad enosine, diffuses further into the tissue than ade nosine, thereby affecting blood flow in a region large enough to be sampled by the 8 5 Kr washout technique.
Consistent with these ideas, increases in CBF were observed in our experiments at 100-and 1,000fold lower concentrations of 2-CADO and NECA, respectively, than of adenosine. Both of these com pounds have been shown to cause relaxation of iso lated cerebral vessels in the concentration range of approximately 10-7 to 10-4 M (McBean et aI., 1988) . However, it is difficult to make direct com parisons of the concentrations at which we ob served increases in CBF to the concentrations at which vascular relaxation occurs in vitro. The con centrations of 2-CADO and NECA at which we first observed significant increases in local CBF (10-5 M 2-CADO, 10-6 M NECA) are not the concentra tions in the tissue, but rather the concentrations present in the artificial CSF that perfused the dial ysis probe. The average concentration of agonist present in the tissue from which CBF is being mea sured is likely to be substantially less than the arti ficial CSF concentration. In addition, even with nonmetabolized compounds, we cannot determine whether the volume of tissue into which the drugs diffuse is the same volume of tissue from which the hydrogen clearance method measures local CBF. Despite these limitations, the observation of greater sensitivity to NECA than to 2-CADO is consistent with the concept that the adenosine receptor on ce rebral vascular smooth muscle is of the adenosine A2 receptor subtype (Kalaria and Harik, 1986; Hardebo et aI., 1987; McBean et aI., 1988) .
There are several potential interpretations of the decrease in dialysate adenosine caused by NECA. First, the increased CBF may simply increase the amount of adenosine washed out of the ISF, result ing in a decrease in ISF adenosine levels. Second, it has been proposed that changes in adenosine pro duction are related to changes in the oxygen sup ply:oxygen demand ratio (Berne, 1963; Barden heuer and Schrader, 1986 ). An increase in oxygen supply, caused by the vasodilator NECA, would increase the ratio, resulting in a decrease in adeno sine production. Third, in addition to adenosine A2 receptor mediation of vasodilation, it is believed that adenosine inhibits excitatory neurotransmis sion via adenosine Al receptors located in the syn aptic regions of neurons (Dunwiddie, 1985) . There fore, NECA, which activates both adenosine Al and A2 receptors (Yeung and Green, 1984; Bruns et aI., 1986) , may decrease neuronal activity via an Armediated mechanism, leading to a diminished adenosine production.
Regardless of the mechanism responsible for the decrease in dialysate adenosine caused by NECA, the reversal of the effect of SPT demonstrates that the decrease in ISF adenosine is initiated by an adenosine receptor-mediated event. Although oth ers have demonstrated that systemically adminis tered theophylline decreases resting CBF (Grome and Stefanovich, 1986; Morii et aI., 1987; Puiroud et aI., 1988) , with our preparation the presence of 10 -3 M SPT in the artificial CSF does not affect control CBF or dialysate adenosine concentration (Van Wylen et aI., 1988a) . Methylxanthines, known adenosme receptor antagonists, have been shown to block the vasodilation of pial vessels induced by topical adenosine suffusion Kuschinsky, 1976, Morii et aI., 1987) and to attenuate increases in CBF induced by hypoxia (Emerson and Ray mond, 198 1; Hoffman et aI., 1984; Morii et aI., 1987) . This suggests that the local infusion of SPT via the brain dialysis technique may be useful in the determination of the contribution of adenosine to CBF regulation. We have utilized this approach of locally infused SPT in two recent studies (Van Wylen et aI., 1988a , 1988b . In one study, SPT was infused via the dialysis probe to determine whether adenosine is involved in the cerebral vasodilation observed in the low blood pressure range of cere bral autoregulation (Van Wylen et aI., 1988a) . At an arterial blood pressure of 50 mm Hg, dialysate ad enosine concentration increased to a greater extent in the presence of SPT as compared to perfusion without SPT, although similar reductions in CBF were observed with or without the antagonist. In another study, SPT infusion attenuated the increase in local CBF induced by local infusion of kainic acid, an agonist of the excitatory neurotransmitter glutamate (Van Wylen et aI., 1988b) .
In summary, this study demonstrates that changes in local CBF and ISF adenosine levels in duced by local infusion of drugs can be measured by the modified dialysis probe. We are hopeful that this approach of local drug infusion and simulta neous measurement of changes in local CBF and ISF adenosine levels will help elucidate the mech anisms of CBF regulation.
